相关实验视频

Updated: Jun 27, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

治疗IA期非小细胞肺癌的治疗策略:基于SEER的人口研究

Bo Wu¹, Xiang Zhang¹, Nan Feng¹

¹Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.

|April 29, 2024

概括

单独的手术 (SA) 是治疗阶段IA非小细胞肺癌 (NSCLC) 的最佳治疗方法,提供最好的生存结果. 在这项综合性分析中,特定的手术程序 - - 脑膜切除术 (lobectomy) 显示出最有利的预后.

科学领域:

在瘤学瘤学.
胸部外科手术胸部外科手术
癌症研究癌症研究

背景情况:

阶段IA非小细胞肺癌 (NSCLC) 提供了多种治疗选择.
缺乏对这些疗法进行系统的比较,以确定最有效的方法.

研究的目的:

为了比较IA期NSCLC的各种治疗方法的有效性.
确定改善整体生存率 (OS) 和肺癌特定生存率 (LCSS) 的最佳治疗策略.

主要方法:

从SEER数据库中利用了2004年至2018年间诊断出IA期NSCLC的89,147名患者的数据.
采用生存分析来比较整个生存率 (OS) 和肺癌特定生存率 (LCSS) 跨治疗组:观察,化疗,放射和各种手术组合.
分析了包括叶切除术,细分切除术,切除术和局部瘤破坏在内的手术方式.

主要成果:

单独的手术 (SA) 显示出最好的 OS 和 LCSS,与观察 (Ref) 相比,危险比率 (HR) 为 0.20.
在外科手术方法中,与局部瘤破坏相比,叶片切除显示出最显著的生存益处 (HR:0.32).
这些发现在各个子组分析中都是一致的,这强调了SA和脑膜切除术的有效性.

结论:

仅仅是手术 (SA) 被认为是治疗IA期NSCLC的最佳治疗方法.
叶切除术与这种患者群体的手术干预中最好的预后有关.
建议进行进一步的前性研究,以验证这些发现并解决潜在的偏见.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...